Skip to main content

Rutgers Rakes in $58M of NIMH, NIDDK Funding for 'Omics Studies

NEW YORK (GenomeWeb News) – Rutgers University has reeled in nearly $58 million from the National Institutes of Health to fund two research programs to conduct genomics studies of mental disorders and of metabolic and digestive diseases, the university said today.
Rutgers said it will use a $42.4 million five-year grant, and a supplemental award of $1.2 million, to create a Center for Genomic Studies on Mental Disorders at the university. The funding for the genomics center will support maintenance of a comprehensive lab, clinical databases, and computational infrastructure to fund national and international research focused on autism, bipolar disorder, depression, obsessive-compulsive disorder, and schizophrenia.
That grant also includes subcontracts to the Washington University School of Medicine to establish clinical and genetic databases, and to the Information Sciences Institute of the University of Southern California, which will study computational technology.

Rutgers also will use a five-year, $14 million contract from the National Institute of Diabetes and Digestive and Kidney Diseases to fund services and infrastructure costs for a cellular and molecular biology lab used for studying digestive, liver, and kidney diseases, and diabetes.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.